Halozyme Therapeutics Inc. buy Wells Fargo & Company
Start price
07.06.24
/
50%
€47.16
Target price
07.06.25
€53.56
Performance (%)
0.95%
End price
08.06.25
€47.61
Summary
This prediction ended on 08.06.25 with a price of €47.61. During the runtime of the prediction for Halozyme Therapeutics Inc. the price only changed by 0.95%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Halozyme Therapeutics Inc. | 5.939% | 5.939% | 45.282% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Wells Fargo & Company from $48.00 to $58.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
In the thread Trading Halozyme Therapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten